CVSG.F Stock Overview
Engages in veterinary, pet crematoria, online pharmacy, and retail businesses. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 2/6 |
| Past Performance | 2/6 |
| Financial Health | 4/6 |
| Dividends | 3/6 |
CVS Group plc Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | UK£11.84 |
| 52 Week High | UK£19.94 |
| 52 Week Low | UK£11.50 |
| Beta | 1.08 |
| 11 Month Change | -15.72% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 33 Year Change | -63.11% |
| 5 Year Change | n/a |
| Change since IPO | -13.88% |
Recent News & Updates
Recent updates
Shareholder Returns
| CVSG.F | US Healthcare | US Market | |
|---|---|---|---|
| 7D | 0% | 1.6% | 2.2% |
| 1Y | n/a | 2.1% | 31.6% |
Return vs Industry: Insufficient data to determine how CVSG.F performed against the US Healthcare industry.
Return vs Market: Insufficient data to determine how CVSG.F performed against the US Market.
Price Volatility
| CVSG.F volatility | |
|---|---|
| CVSG.F Average Weekly Movement | n/a |
| Healthcare Industry Average Movement | 6.8% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in US Market | 15.7% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: CVSG.F's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: Insufficient data to determine CVSG.F's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1999 | 8,822 | Richard William Fairman | www.cvsukltd.co.uk |
CVS Group plc, together with its subsidiaries, engages in veterinary, pet crematoria, online pharmacy, and retail businesses. The company operates through Veterinary Practices, Laboratories, Crematoria, and Online Retail Business segments. It operates in animal veterinary practices and complementary veterinary diagnostic businesses.
CVS Group plc Fundamentals Summary
| CVSG.F fundamental statistics | |
|---|---|
| Market cap | US$749.97m |
| Earnings (TTM) | US$32.92m |
| Revenue (TTM) | US$813.32m |
22.8x
P/E Ratio0.9x
P/S RatioIs CVSG.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CVSG.F income statement (TTM) | |
|---|---|
| Revenue | UK£647.30m |
| Cost of Revenue | UK£369.40m |
| Gross Profit | UK£277.90m |
| Other Expenses | UK£251.70m |
| Earnings | UK£26.20m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
Feb 27, 2025
| Earnings per share (EPS) | 0.37 |
| Gross Margin | 42.93% |
| Net Profit Margin | 4.05% |
| Debt/Equity Ratio | 69.6% |
How did CVSG.F perform over the long term?
See historical performance and comparison